KARBE FRANK — SEC Form 4 filings
SEC reporting owner CIK 1276700. 8 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-24 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 12,500 shares, $99,084 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 12,500 shares @ $7.93 ($99,084) in Phathom Pharmaceuticals, Inc., filed 2024-12-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | Director | 5 | 1 leg · 12,500 sh · $99,084 | — | 6 |
| Cidara Therapeutics, Inc. (CDTX) | Chief Financial Officer | 3 | — | — | 6 |
Form 4 filings — KARBE FRANK
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-21 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 24,122 @ $0 | EDGAR |
| 2026-01-07 | 4 | Cidara Therapeutics, Inc. (CDTX) | Disposition to issuer (D): 7,526 @ $221.50 · Disposition to issuer (D): 43,125 · Disposition to issuer (D): 115,000 (derivative) | EDGAR |
| 2025-12-12 | 4 | Cidara Therapeutics, Inc. (CDTX) | Tax withholding (F): 7,290 @ $219.60 | EDGAR |
| 2025-06-05 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | Cidara Therapeutics, Inc. (CDTX) | Grant/award (A): 57,500 @ $0 · Grant/award (A): 115,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Purchase (P): 12,500 @ $7.93 | EDGAR |
| 2024-05-31 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 25,000 @ $10.16 | EDGAR |
| 2024-05-24 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1276700 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →